Drugs / 68Ga-FAPI-Biotin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06740240 | Mar 2024 → Jun 2026 overdue | neoplasm | First Affiliated Hospital of Fujian Medical University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68Ga-FAPI-Biotin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06740240 ↗ |
| Modality | Diagnostic / imaging agent | “As a new dual targeting PET radiotracer, 68Ga-FAPI-Biotin is promising as an excellent imaging agent” NCT06740240 ↗ |